ENFN vs. LIN

Last updated Jun 3, 2026

ENFN (Enfusion, Inc.) and LIN (Linde plc) are both stocks. ENFN operates in Software - Application (Technology), while LIN operates in Specialty Chemicals (Basic Materials).

Performance

ENFN vs. LIN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enfusion, Inc. (ENFN) and Linde plc (LIN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ENFN

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

LIN

• 1D: -0.30%
• 1M: -2.36%
• YTD: 16.69%
• 6M: 22.17%
• 1Y: 8.19%
• 3Y*: 12.53%
• 5Y*: 12.14%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ENFN vs. LIN - Yearly Performance Comparison

	2026 (YTD)
ENFN Enfusion, Inc.	0.00%
LIN Linde plc	11.01%

Fundamentals

Total Revenue (TTM) ENFN : $201.61M LIN : $34.66B
Gross Profit (TTM) ENFN : $136.74M LIN : $15.94B
EBITDA (TTM) ENFN : $14.66M LIN : $12.31B

Return for Risk

ENFN vs. LIN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LIN

LIN Risk / Return Rank: 50
LIN Sharpe Ratio Rank: 57
LIN Sortino Ratio Rank: 48
LIN Omega Ratio Rank: 46
LIN Calmar Ratio Rank: 49
LIN Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENFN vs. LIN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enfusion, Inc. (ENFN) and Linde plc (LIN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ENFN	LIN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.49	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.59	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.70	—

Drawdowns

ENFN vs. LIN - Drawdown Comparison

The maximum ENFN drawdown since its inception was 0.00%, smaller than the maximum LIN drawdown of -32.59%. Use the drawdown chart below to compare losses from any high point for ENFN and LIN.

Drawdown Indicators

	ENFN	LIN	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-32.59%	+32.59%
Max Drawdown (1Y) Largest decline over 1 year	—	-19.18%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-19.18%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-22.82%	—
Current Drawdown Current decline from peak	0.00%	-4.19%	+4.19%
Average Drawdown Average peak-to-trough decline	0.00%	-5.43%	+5.43%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	6.80%	—

Volatility

Volatility by Period

	ENFN	LIN	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	5.72%	—
Volatility (6M) Calculated over the trailing 6-month period	—	13.35%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	16.86%	-16.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	20.75%	-20.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	24.08%	-24.08%

Dividends

ENFN vs. LIN - Dividend Comparison

ENFN has not paid dividends to shareholders, while LIN's dividend yield for the trailing twelve months is around 1.23%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
ENFN Enfusion, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LIN Linde plc	1.23%	1.41%	1.33%	1.24%	1.43%	1.22%	1.46%	1.64%	0.53%

Financials